Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $81.73

Henry Schein, Inc. (NASDAQ:HSIC) has been given a consensus recommendation of “Hold” by the eleven ratings firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $81.73.

HSIC has been the subject of several recent research reports. Piper Sandler reiterated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Barrington Research lifted their price target on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. JPMorgan Chase & Co. increased their price objective on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. UBS Group reduced their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Finally, Jefferies Financial Group increased their price target on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th.

Henry Schein Trading Down 0.7 %

NASDAQ:HSIC opened at $64.09 on Tuesday. The stock’s 50-day moving average is $70.04 and its two-hundred day moving average is $72.94. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The stock has a market cap of $8.21 billion, a PE ratio of 21.65, a price-to-earnings-growth ratio of 1.63 and a beta of 0.90. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. The firm’s revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.21 earnings per share. As a group, equities research analysts forecast that Henry Schein will post 5.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HSIC. Swedbank AB acquired a new stake in shares of Henry Schein in the first quarter worth $215,998,000. Wahed Invest LLC boosted its holdings in Henry Schein by 14.3% in the 1st quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock valued at $192,000 after purchasing an additional 318 shares during the period. Tidal Investments LLC grew its position in Henry Schein by 21.4% in the 1st quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock worth $425,000 after purchasing an additional 994 shares during the last quarter. California State Teachers Retirement System increased its holdings in shares of Henry Schein by 1.7% during the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock worth $16,018,000 after purchasing an additional 3,534 shares during the period. Finally, Magnetar Financial LLC raised its position in shares of Henry Schein by 229.9% during the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock valued at $29,185,000 after buying an additional 269,330 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.